| Home | E-Submission | Sitemap | Contact Us |  
top_img
J Korean Cancer Assoc > Volume 28(2); 1996 > Article
Journal of the Korean Cancer Association 1996;28(2): 236-247.
담도계 및 췌장암의 악성 담도폐색에 있어서 새로운 막부착성 팽창성 금속제 담도배액관 ( Covered Modified - Giantruco Biliary Stent ) 의 개발 및 임상성적 )
심찬섭, 조영덕, 봉형근, 김진오, 조주영, 김연수, 이준성, 이문성, 황성규, 신경민
담도계 및 췌장암의 악성 담도폐색에 있어서 새로운 막부착성 팽창성 금속제 담도배액관 ( Covered Modified - Giantruco Biliary Stent ) 의 개발 및 임상성적
Chan Sup Shim, Young Deok Cho, hyung Keun Bon, Jin Oh Kim, Joo Young Cho, Yun Soo Kim, Joon Seong Lee, Moon Sung Lee, Seong Gyu Hwang, Kyung Min Shin
ABSTRACT
Background: The biliary stents in current use have a tendency to be blocked. In order to maintain long-term patency of stent a larger diameter of biliary stent is needed and the expandable metal stents(EMS) have been developed. But tumor ingrowth was frequently observed in uncovered self-EMS. To overcome the limitations of uncovered self-EMSs, we developed self-EMS covered with polyurethane or polytetrafluoroethylene(PTFE) which was used as artificial vessel. This stent would have more advantages than uncovered self- EMS. Aim: To evaluate the successfulness and the effectiveness of new membrane covered self-EMS(covered modified-Gianturco biliary stent) with polyurethane or PTFE, we studied in patients with malignant biliary obstruction due to biliopancreatic carcinoma.
Method:
We developed self-EMS covered with polyurethane or PTFE, and applied covered self-EMS through endoscopic transpapillary or percutaneous transhepatic route in l8 patients of malignant biliary obstruction and 2 benign stricture. We followed-up the patients monthiy with ultrasonography, clinical symptoms and liver function test. There were 13 men and 7 women. The mean age in inrolled patients was 65.6¡¾7.9 year. 10 had CBD cancer, 7 pancreatic head cancer, 1 ampulla of Vater cancer, and 2 benign intrahepatic bile duct stricture.
Results:
The success rate of covered self-EMS insertion through peroral transpapillary route was 84.6%(11/13) on first trial. In 2 patients with malignant biliary obstruction we couldn't insert covered self-EMS because of technical problems in introducing system, but sucessfully inserted on second trial. And through the Percutaneous transhepatic route, we could also sucessfully applied covered self-EMS in all patients(7/7). There were no complications associated to the procedure of stent implantation. In one case the stent was dislodged spontaneously after 1.3 month, and one patient died after 1 month due to pulmonary metastasis. There was no evidence of biliary reobstruction during follow-up period d[median follow-up 6.75(l.312) months in PTFE patients(4) and 2(l 10) months in polyurethane patients(16)].
Conclusion:
We expect that new membrane covered self-EMS has long-term patency and adequacy of biliary drainage, but we cannot completely evaluate the disadvantage of this stent until now due to short-term follow up.
Key words: Polyurethane, Polytetrafluoroethylene(PTFE), Membrane covered self- expandable metal stent, Malignant biliary obstruction
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Share:      
METRICS
2,231
View
15
Download
Related article
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI